Pfizer Recalls Robitussin Peak Cold Liquid Due to Labeling Error
Pfizer is recalling 63,636 bottles of Robitussin Peak Cold Liquid nationwide due to a label mix-up. Consumers should stop using the product and return it to the point of purchase.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The specific hazard is a labeling error.
Plain-English summary
Pfizer Inc is voluntarily recalling 63,636 bottles of Adult Robitussin PEAK COLD Cough & Chest Congestion DM Liquid (8 oz. / 237 mL). The recall is being conducted due to a labeling error described as a "Label Mix-Up." The affected product is identified by Lot # R29364 and has an expiration date of 10/17.
The product was distributed nationwide. The U.S. Food and Drug Administration has classified this recall as Class III, which indicates that use of or exposure to the violative product is not likely to cause adverse health consequences.
Consumers who have this product should stop using it and return it to the place of purchase for a refund or contact Pfizer for further instructions.
The recalled product
- Product
- Adult Robitussin PEAK COLD Cough & Chest Congestion DM Liquid 8 oz. Bottle (237 mL), Distributed by Pfizer, Madison, NJ 07940, NDC 0031-8736-18
- Manufacturer
- Pfizer Inc
- Hazard
- Affected units
- 63,636
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: R29364
- Exp. 10/17
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Pfizer Inc
See all →- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateChildren's Robitussin DM Recalled for Missing Dosing Cup Graduations
FDA (Drugs) · 2020-07-08
- ModerateChildren's Dimetapp Cold & Cough Recalled for Missing Dosing Cup Graduations
FDA (Drugs) · 2020-07-08
- LowPfizer Recalls Ethosuximide Capsules Due to Incorrect Expiration Date Labeling
FDA (Drugs) · 2019-10-02
- SevereGeritrex Recalls Ritussin DM Due to Potential Microbial Contamination
FDA (Drugs) · 2019-07-31
- LowPfizer Recalls Zarontin Capsules Due to Incorrect Expiration Date Labeling
FDA (Drugs) · 2019-10-02
- ModeratePerrigo Recalls Children's Guaifenesin DM Liquid Due to Dosing Cup Errors
FDA (Drugs) · 2016-02-03